首页> 外文期刊>Genetics in medicine >ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)
【24h】

ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)

机译:ACMG遗传性大肠癌(Lynch综合征,家族性腺瘤性息肉病和MYH相关性息肉病)基因测试的技术标准和指南

获取原文
获取原文并翻译 | 示例
           

摘要

Lynch syndrome, familial adenomatous polyposis, and Mut Y homolog (MYH)-associated polyposis are three major known types of inherited colorectal cancer, which accounts for up to 5% of all colon cancer cases. Lynch syndrome is most frequently caused by mutations in the mismatch repair genes MLH1, MSH2, MSH6, and PMS2 and is inherited in an autosomal dominant manner. Familial adenomatous polyposis is manifested as colonic polyposis caused by mutations in the APC gene and is also inherited in an autosomal dominant manner. Finally, MYH-associated polyposis is caused by mutations in the MUTYH gene and is inherited in an autosomal recessive manner but may or may not be associated with polyps. There are variants of both familial adenomatous polyposis (Gardner syndrome-with extracolonic features-and Turcot syndrome, which features medulloblastoma) and Lynch syndrome (Muir-Torre syndrome features sebaceous skin carcinomas, and Turcot syndrome features glioblastomas). Although a clinical diagnosis of familial adenomatous polyposis can be made using colonoscopy, genetic testing is needed to inform at-risk relatives. Because of the overlapping phenotypes between attenuated familial adenomatous polyposis, MYH-associated polyposis, and Lynch syndrome, genetic testing is needed to distinguish among these conditions. This distinction is important, especially for women with Lynch syndrome, who are at increased risk for gynecological cancers. Clinical testing for these genes has progressed rapidly in the past few years with advances in technologies and the lower cost of reagents, especially for sequencing. To assist clinical laboratories in developing and validating testing for this group of inherited colorectal cancers, the American College of Medical Genetics and Genomics has developed the following technical standards and guidelines. An algorithm for testing is also proposed.
机译:Lynch综合征,家族性腺瘤性息肉病和Mut Y同源物(MYH)相关性息肉病是三种已知的遗传性结直肠癌主要类型,占所有结肠癌病例的5%。林奇综合症最常见的原因是失配修复基因MLH1,MSH2,MSH6和PMS2发生突变,并以常染色体显性方式遗传。家族性腺瘤性息肉病表现为由APC基因突变引起的结肠息肉病,并且也以常染色体显性遗传。最后,MYH相关性息肉病是由MUTYH基因突变引起的,并以常染色体隐性方式遗传,但可能与息肉无关。家族性腺瘤性息肉病(加德纳综合征-具有结肠外特征-和Turcot综合征具有髓母细胞瘤)和Lynch综合征(Muir-Torre综合征具有皮脂性皮肤癌,Turcot综合征具有胶质母细胞瘤)都有变体。尽管可以使用结肠镜检查对家族性腺瘤性息肉病进行临床诊断,但仍需要进行基因检测以告知高危亲属。由于减毒的家族性腺瘤性息肉病,MYH相关性息肉病和Lynch综合征之间存在重叠的表型,因此需要进行基因检测以区分这些情况。这种区别非常重要,尤其是对于Lynch综合征妇女,她们患妇科癌症的风险增加。随着技术的进步和试剂成本的降低(尤其是用于测序),这些基因的临床测试在过去几年中取得了飞速的发展。为了帮助临床实验室开发和验证针对这组遗传性结直肠癌的检测,美国医学遗传学和基因组学学院制定了以下技术标准和指南。还提出了一种测试算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号